Inhibition of histone deacetylases 3 attenuates imiquimod-induced psoriatic dermatitis via targeting cGAS-STING signaling in keratinocytes
Open Access
- 2 June 2025
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 23 (1) , 1-20
Abstract
Psoriasis is a common chronic inflammatory skin disease characterized by epidermal keratinocyte hyperproliferation and persistent immune activation. Histone deacetylase 3 (HDAC3), a member of the class I HDAC family, plays critical roles in regulating immunity and inflammation. However, its precise expression profile and functional contribution to psoriasis pathogenesis remain poorly defined. We first performed bioinformatics analysis of HDAC3 expression using the Gene Expression Omnibus (GEO) database. Subsequently, we employed a combination of cellular and molecular techniques, including hematoxylin and eosin (H&E) staining, immunohistochemistry, flow cytometry, quantitative real-time PCR (qRT-PCR), western blotting, and transmission electron microscopy (TEM), to analyze the role of HDAC3 in IMQ-induced psoriasis-like inflammation in mice and in vitro psoriasis models. HDAC3 expression was significantly upregulated in psoriasis lesions of patients and in both in vitro and in vivo models of psoriasis. Pharmacological inhibition of HDAC3 using the specific inhibitor RGFP966 alleviated IMQ-induced skin inflammation in mice and suppressed psoriasis-like phenotypes in vitro. Mechanistically, HDAC3 upregulation in an inflammatory microenvironment promoted oxidative stress, disrupted mitochondrial structural integrity, and triggered mitochondrial DNA leakage into the cytosol, thereby activating the cGAS-STING pathway in keratinocytes. Our findings establish HDAC3 as a pivotal mediator of psoriasis pathogenesis through the cGAS-STING pathway via mitochondrial dysfunction. The role of HDAC3 in exacerbating epidermal hyperproliferation and inflammation highlights its potential as a therapeutic target. Targeting HDAC3 in keratinocytes may offer a novel strategy for preventing and treating psoriasis by modulating epigenetic regulation, mitochondrial homeostasis, and innate immune responses.Keywords
Funding Information
- National Natural Science Foundation of China (82303994)
This publication has 66 references indexed in Scilit:
- Mitochondrial DNA-activated cGAS-STING pathway in cancer: Mechanisms and therapeutic implicationsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024
- Evaluation of Pro‐BNP biomarker in heart failure patients and its relationship with complete blood count parameters: A case–control studyHealth Science Reports, 2024
- Histone deacetylase complexes: Structure, regulation and functionBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024
- A Nanoinhibitor Targeting cGAS‐STING Pathway to Reverse the Homeostatic Imbalance of Inflammation in PsoriasisAngewandte Chemie International Edition, 2023
- Tranexamic acid improves psoriasis-like skin inflammation: Evidence from in vivo and in vitro studiesBiomedicine & Pharmacotherapy, 2023
- HDAC3 Inhibition Stimulates Myelination in a CMT1A Mouse ModelMolecular Neurobiology, 2022
- Overexpression of miR-132-3p contributes to neuronal protection in in vitro and in vivo models of Alzheimer’s diseaseBehavioural Brain Research, 2022
- Pathophysiology, Clinical Presentation, and Treatment of PsoriasisJAMA, 2020
- Keratinocyte: A trigger or an executor of psoriasis?Journal of Leukocyte Biology, 2020
- JHDM1D and HDAC1–3 mRNA expression levels in peripheral blood mononuclear cells of patients with systemic lupus erythematosusZeitschrift für Rheumatologie, 2015